{
    "title": "110_hr6376",
    "content": "SECTION 1. SHORT TITLE.\n\n    This Act may be cited as the ``Strengthening of FDA Integrity Act \nof 2008''.\n\nSEC. 2. DEBARMENT.\n\n    (a) Application to Drugs, Biological Products, and Devices.--The \nFederal Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.) is \namended--\n            (1) in section 201, by amending subsection (dd) to read as \n        follows:\n    ``(dd) The term `drug product'--\n            ``(1) for purposes of sections 306 and 307, means a drug \n        subject to regulation under section 505, 512, or 802 of this \n        Act or under section 351 of the Public Health Service Act; and\n            ``(2) for purposes of section 306, includes a device \n        subject to regulation under section 513 of this Act.''; and\n            (2) in section 306--\n                    (A) by striking the term ``an abbreviated drug \n                application'' each place such term appears and \n                inserting ``a covered application'';\n                    (B) by striking the terms ``abbreviated drug \n                application'' and ``abbreviated drug applications'' \n                each place either such term appears and inserting \n                ``covered application'' and ``covered applications'', \n                respectively;\n                    (C) by striking the term ``drug product \n                application'' each place such term appears and \n                inserting ``covered application'';\n                    (D) in the heading of subsections (a) and (b), by \n                striking ``Certain Drug Applications'' and inserting \n                ``Certain Drug Product Applications'';\n                    (E) in subsection (b)(2)(B)(i), by striking ``the \n                process for the regulation of drugs'' and inserting \n                ``the process for the regulation of drug products'';\n                    (F) in subsection (d)(4)(B)(ii), by striking ``of \n                any drug subject to sections 505'' and inserting ``of \n                any drug product'';\n                    (G) in subsections (b)(2)(A), (b)(2)(B)(iv), \n                (c)(3)(C), (c)(3)(E), (d)(3)(A)(ii)(II), (d)(3)(B)(ii), \n                (d)(4)(B)(iv), (d)(4)(D)(ii), (f)(1)(B)(ii), (g), and \n                (h), by striking the terms ``drug'' and ``drugs'' each \n                place either such term appears and inserting ``drug \n                product'' and ``drug products'', respectively; and\n                    (H) by adding at the end the following:\n    ``(n) Covered Application Defined.--In this section, the term \n`covered application' means--\n            ``(1) an application for approval or licensure of a drug \n        under section 505 of this Act or section 351 of the Public \n        Health Service Act, respectively; or\n            ``(2) an application for clearance or approval of a device \n        under section 510(k) or 515 of this Act, respectively.''.\n    (b) Mandatory Debarment.--Paragraph (1) of section 306(a) of the \nFederal Food, Drug, and Cosmetic Act (21 U.S.C. 335a(a)) is amended to \nread as follows:\n            ``(1) Corporations, partnerships, and associations.--If the \n        Secretary finds that a person other than an individual has been \n        convicted, after May 13, 1992, of a felony under Federal law \n        for conduct--\n                    ``(A) relating to the development or approval, \n                including the process for development or approval, of \n                any drug product, or\n                    ``(B) otherwise relating to the regulation of any \n                drug product under this Act or subpart 1 of part F of \n                title III of the Public Health Service Act,\n        the Secretary shall debar such person from submitting, or \n        assisting in the submission of, any covered application.''.\n    (c) Permissive Debarment.--Section 306(b)(2) of the Federal Food, \nDrug, and Cosmetic Act (21 U.S.C. 335a(b)(2)) is amended--\n            (1) in subparagraph (A)(i), by amending subclause (I) to \n        read as follows:\n                                    ``(I) relates to the development or \n                                approval, including the process for \n                                development or approval, of any drug \n                                product or otherwise relates to the \n                                regulation of drug products under this \n                                Act or subpart 1 of part F of title III \n                                of the Public Health Service Act, \n                                and'';\n            (2) in subparagraph (B)--\n                    (A) by striking clauses (ii) and (iii); and\n                    (B) by redesignating clause (iv) as clause (ii); \n                and\n            (3) by adding at the end the following:\n                    ``(C) Bribery, fraud, and other such crimes.--Any \n                person (including any individual) whom the Secretary \n                finds has been convicted of--\n                            ``(i) a felony which is not described in \n                        paragraph (1) or (2) of subsection (a) or in \n                        subparagraph (A) or (B)(i) of this subsection \n                        and which involves bribery, payment of illegal \n                        gratuities, fraud, perjury, false statement, \n                        racketeering, blackmail, extortion, \n                        falsification or destruction of records, or \n                        interference with or obstruction of an \n                        investigation into, or prosecution of, any \n                        criminal offense, or\n                            ``(ii) a conspiracy to commit, or aiding or \n                        abetting such felony,\n                if the Secretary finds, on the basis of the conviction \n                of such person and other information, that such person \n                has demonstrated a pattern of conduct sufficient to \n                find that there is reason to believe that such person \n                may violate requirements under this Act or subpart 1 of \n                part F of title III of the Public Health Service Act \n                relating to drug products.\n                    ``(D) Material participation.--Any person \n                (including any individual) whom the Secretary finds \n                materially participated in acts that were the basis for \n                a conviction for an offense described in paragraph (1) \n                or (2) of subsection (a) or in subparagraph (A), \n                (B)(i), or (C) of this subsection for which a \n                conviction was obtained, if the Secretary finds, on the \n                basis of such participation and other information, that \n                such individual has demonstrated a pattern of conduct \n                sufficient to find that there is reason to believe that \n                such person may violate requirements under this Act or \n                subpart 1 of part F of title III of the Public Health \n                Service Act relating to drug products.''.\n    (d) Additional Debarment Consideration.--Paragraph (3) of \nsubsection (c) of section 306 of the Federal Food, Drug, and Cosmetic \nAct (21 U.S.C. 335a(c)(3)) is amended--\n            (1) by striking ``and'' at the end of subparagraph (E);\n            (2) by striking the period at the end of subparagraph (F) \n        and inserting ``, and''; and\n            (3) by adding at the end the following new subparagraph:\n                    ``(G) whether debarment of the person will affect \n                the public health because sufficient quantities of the \n                drug product would not be available.''.\n    (e) Effective Dates.--Paragraph (2) of section 306(l) of the \nFederal Food, Drug, and Cosmetic Act (21 U.S.C. 335a(l)) is amended by \nstriking the phrase ``occurred more than 5 years before'' each place \nsuch phrase appears and inserting ``occurred more than 1 year before''.\n    (f) Annual Report.--Section 306 of the Federal Food, Drug, and \nCosmetic Act (21 U.S.C. 335a) is amended by adding at the end the \nfollowing:\n    ``(o) Annual Report.--Each year, the Secretary shall submit a \nreport to the Congress on implementation of this section. Each such \nreport shall identify--\n            ``(1) debarment proceedings mandated under subsection (a) \n        or (m);\n            ``(2) debarment proceedings initiated under subsection (a), \n        (b), or (m);\n            ``(3) the status of debarment proceedings so initiated or \n        pending from a previous year;\n            ``(4) debarments imposed under this section; and\n            ``(5) debarments declined under this section.''.\n    (g) Conforming Amendments.--Section 306 of the Federal Food, Drug, \nand Cosmetic Act (21 U.S.C. 335a) is amended--\n            (1) in subsections (a)(2)(B) and (h)(1)(A), by striking \n        ``this Act'' and inserting ``this Act or subpart 1 of part F of \n        title III of the Public Health Service Act'';\n            (2) in subsection (b)(2)(A)(i)(II), by striking ``the date \n        of the enactment of this section'' and inserting ``May 13, \n        1992'';\n            (3) in subsection (b)(4), by striking ``clause (iii) or \n        (iv) of paragraph (2)(B)'' and inserting ``subparagraph (B)(ii) \n        or (D) of paragraph (2)'';\n            (4) in subsection (c)(1)(A), by striking ``subsection \n        (a)(1) or (b)(2)(A)'' and inserting ``subsection (a)(1) or \n        (b)(1)(A)'';\n            (5) in subsection (c)(1)(B), by striking ``subsection \n        (a)(2) or (b)(2)(B)'' and inserting ``subsection (a)(2) or \n        (b)(1)(B)'';\n            (6) in subsection (d)(3)(A)(i), by striking ``or paragraph \n        (2)(A) or (3) of subsection (b)'' and inserting ``subparagraph \n        (A) or (C) of subsection (b)(1)'';\n            (7) in subsection (d)(3)(B)(i), by striking ``clause (i), \n        (ii), (iii), or (iv) of subsection (b)(2)(B) or subsection \n        (b)(3)'' and inserting ``subparagraph (B) or (C) of subsection \n        (b)(1)'';\n            (8) in subsection (d)(3)(B)(ii), by striking ``under \n        subsection (b)(2)(B) or subsection (b)(3)'' and inserting \n        ``under subparagraph (B) or (C) of subsection (b)(1)'';\n            (9) in subsection (j)(2), by striking ``clause (iii) or \n        (iv) of subsection (b)(2)(B)'' and inserting ``subparagraph \n        (B)(ii) or (D) of subsection (b)(2)''; and\n            (10) in subsection (l)(2)--\n                    (A) by striking ``clauses (i) and (ii) of \n                subsection (b)(2)(B)'' and inserting ``subparagraphs \n                (B)(i) and (C) of subsection (b)(2)'';\n                    (B) by striking ``Clauses (iii) and (iv) of \n                subsection (b)(2)(B)'' and inserting ``Subparagraphs \n                (B)(ii) and (D) of subsection (b)(2)''; and\n                    (C) by striking ``Clause (iv) of subsection \n                (b)(2)(B)'' and inserting ``Subparagraph (B)(ii) of \n                subsection (b)(2)''."
}